PainReform Ltd. Announces Reverse Share Split
Ticker: PRFX · Form: 6-K · Filed: Sep 4, 2024 · CIK: 1801834
| Field | Detail |
|---|---|
| Company | Painreform Ltd. (PRFX) |
| Form Type | 6-K |
| Filed Date | Sep 4, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reverse-stock-split, corporate-action, filing-update
TL;DR
PainReform doing a reverse stock split Friday, Sept 6th. Get ready for share consolidation.
AI Summary
PainReform Ltd. announced on September 4, 2024, that it will implement a reverse share split of its ordinary shares after market close on Friday, September 6, 2024. This action is being incorporated by reference into several of the Company's existing registration statements on Forms S-8 and F-3.
Why It Matters
A reverse stock split can impact a company's share price and market perception, potentially affecting investor interest and trading dynamics.
Risk Assessment
Risk Level: medium — Reverse stock splits can sometimes signal underlying financial challenges or be used to meet exchange listing requirements, which can introduce uncertainty.
Key Players & Entities
- PainReform Ltd. (company) — Registrant
- September 6, 2024 (date) — Effective date of reverse share split
- Form S-8 (document) — Incorporated by reference
- Form F-3 (document) — Incorporated by reference
FAQ
What is the purpose of the reverse share split?
The filing does not explicitly state the purpose of the reverse share split, but it is a common corporate action to adjust the number of outstanding shares and the per-share price.
When will the reverse share split take effect?
The reverse share split will take effect after market close on Friday, September 6, 2024.
What is the ratio of the reverse share split?
The filing announces that a reverse share split will occur but does not specify the ratio.
Which registration statements will this Form 6-K be incorporated into?
This Form 6-K is incorporated by reference into the Company's Registration Statements on Form S-8 (Registration No. 333-257968 and 333-265902) and Form F-3 (Registration No. 333-259318, 333-254982, 333-276485 and 333-277594).
Is PainReform Ltd. a foreign private issuer?
Yes, the Form 6-K is titled 'Report of Foreign Private Issuer'.
Filing Stats: 348 words · 1 min read · ~1 pages · Grade level 11.6 · Accepted 2024-09-04 16:16:00
Filing Documents
- zk2431986.htm (6-K) — 9KB
- 0001178913-24-002957.txt ( ) — 10KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: September 4, 2024 PAINREFORM LTD. By: /s/ Ehud Geller Ehud Geller Interim Chief Executive Officer